The AlphaLISA™ SureFire® Ultra™ Human Phospho-HSP27 (Ser15) assay is a sandwich immunoassay for quantitative detection of phopho-HSP27 (Ser15) in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Heat shock protein 27 (Hsp27) is a protein that in humans is encoded by the HSPB1 gene. Hsp27 is a multidimensional protein which acts as a protein chaperone and an antioxidant and plays a role in the inhibition of apoptosis and actin cytoskeletal remodeling. In each of these capacities, HSP27 has been implicated in different disease states playing both protective and counter-protective roles. This protein has been indicated in renal injury, fibrosis, cancer, neurodegenerative disease, and cardiovascular disease.
The AlphaLISA SureFire Human Phospho-HSP27 (Ser15) Detection Kit is a sandwich immunoassay for the quantitative detection of phospho-HSP27 (Ser15) in cellular lysates, using Alpha Technology.
Application |
Protein Analysis & Detection
Protein Detection
|
---|---|
Assay Points |
500
|
Assay Target |
HSP27
|
Assay Target Class |
Phospho-protein
|
Assay Technology |
Alpha
|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Method |
Alpha
|
Experimental Type |
In vitro
|
Shipping Conditions |
Shipped in Blue Ice
|
Target Species |
Human
|
Therapeutic Area |
Cardiovascular
Metabolic
Neuroscience
Oncology
|
Unit Size |
500 Assay Points
|
Therapeutic antibodies directed to cell surface receptors are increasingly being developed as treatments for a variety of diseases...
The measurement of protein phosphorylation is a useful tool for measuring the modulation of receptor activation by both antibodies...
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.